AR015987A1 - DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO. - Google Patents

DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO.

Info

Publication number
AR015987A1
AR015987A1 ARP980105377A ARP980105377A AR015987A1 AR 015987 A1 AR015987 A1 AR 015987A1 AR P980105377 A ARP980105377 A AR P980105377A AR P980105377 A ARP980105377 A AR P980105377A AR 015987 A1 AR015987 A1 AR 015987A1
Authority
AR
Argentina
Prior art keywords
preparation
pharmaceutical composition
composition containing
medicinal product
nch2coo
Prior art date
Application number
ARP980105377A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26312507&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015987(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9722817.5A external-priority patent/GB9722817D0/en
Priority claimed from GBGB9813689.8A external-priority patent/GB9813689D0/en
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of AR015987A1 publication Critical patent/AR015987A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/36—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Abstract

Derivados de pleuromutilina en los que el resto de éster glicolico en la posicion 14 está sustituido con R2(CH2)mX(CH2)nCH2COO y que se usan en terapiaantimicrobiana, de formula general (IA) o (IB), en las cuales: cada uno de n y m esindependienteme nte 0, 1 o 2; X se selecciona entre -O-, -S-, -S(O)-, -SO2-,-CO.O-, -NH-, -CONH-, -NHCONH- y un enlace; R1 es vinilo o etilo; R2 es un grupo monocíclico o bicíclico no aromático que contiene uno o dos átomos denitrogeno básicos yestá unido a través de un átomo de C del anillo; R3 es H u OH; o el resto R3(CH2)mX(CH2)nCH2COO en la posicion 14 de (IA) o (IB) estásustituido con RaRbC=CHCOO en el que uno de Ra y Rb es hidrogeno y el otro es R3, o Ra y Rb forman conjuntamente R2,o una sal farmacéut icamente aceptable delmismo; procedimiento para su preparacion, composicion farmacéutica que los contienen, su uso para la elaboracion de un medicamento y un compuestointermediario.
ARP980105377A 1997-10-29 1998-10-27 DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO. AR015987A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722817.5A GB9722817D0 (en) 1997-10-29 1997-10-29 Novel compounds
GBGB9813689.8A GB9813689D0 (en) 1998-06-25 1998-06-25 Novel compounds

Publications (1)

Publication Number Publication Date
AR015987A1 true AR015987A1 (es) 2001-05-30

Family

ID=26312507

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105377A AR015987A1 (es) 1997-10-29 1998-10-27 DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO.

Country Status (36)

Country Link
US (3) USRE39128E1 (es)
EP (3) EP1028961B3 (es)
JP (2) JP4227729B2 (es)
KR (1) KR100538721B1 (es)
CN (1) CN1205211C (es)
AR (1) AR015987A1 (es)
AT (2) ATE525373T1 (es)
AU (1) AU742167C (es)
BR (1) BR9814747B1 (es)
CA (1) CA2307551C (es)
CO (1) CO5021129A1 (es)
CY (2) CY2007028I1 (es)
CZ (1) CZ298543B6 (es)
DE (2) DE122007000076I2 (es)
DK (2) DK1028961T5 (es)
DZ (1) DZ2634A1 (es)
EG (1) EG24177A (es)
ES (2) ES2229538T7 (es)
FR (1) FR07C0057I2 (es)
HK (1) HK1031376A1 (es)
HU (2) HU229792B1 (es)
IL (2) IL135811A0 (es)
LU (1) LU91372I2 (es)
MY (1) MY130665A (es)
NL (1) NL300304I2 (es)
NO (3) NO327392B1 (es)
NZ (1) NZ504203A (es)
PE (1) PE123299A1 (es)
PL (2) PL191927B1 (es)
PT (2) PT1930330E (es)
SI (2) SI1930330T1 (es)
TR (1) TR200001203T2 (es)
TW (1) TWI232861B (es)
UY (1) UY25225A1 (es)
WO (1) WO1999021855A1 (es)
ZA (1) ZA989767B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (en) * 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB9912657D0 (en) * 1999-06-01 1999-07-28 Smithkline Beecham Plc Novel compounds
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB9919839D0 (en) * 1999-08-20 1999-10-27 Smithkline Beecham Plc Novel compounds
BR0109809A (pt) * 2000-04-04 2003-01-21 Smithkline Beecham Plc Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano
GB0017073D0 (en) * 2000-07-11 2000-08-30 Univ London Microorganism
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0024811D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
GB0027705D0 (en) * 2000-11-11 2000-12-27 S P A Novel compounds
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
ES2295657T3 (es) * 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
US7875630B2 (en) * 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
GB0504314D0 (en) * 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
EP1860943A4 (en) * 2005-03-10 2008-06-18 Smithkline Beecham Corp NOVEL PROCEDURE
WO2007000004A1 (en) * 2005-06-27 2007-01-04 Nabriva Therapeutics Forschungs Gmbh Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
WO2007037518A1 (ja) * 2005-09-29 2007-04-05 Dainippon Sumitomo Pharma Co., Ltd. ムチリン誘導体及びそれを含有する医薬組成物
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
KR20090107567A (ko) 2007-02-09 2009-10-13 아스텔라스세이야쿠 가부시키가이샤 아자 가교환 화합물
WO2008117796A1 (ja) * 2007-03-28 2008-10-02 Dainippon Sumitomo Pharma Co., Ltd. 新規ムチリン誘導体
EP2149571A4 (en) 2007-05-24 2010-09-01 Kyorin Seiyaku Kk MUTILINE DERIVATIVE WITH A RINGED, HETEROCYCLIC AND AROMATIC CARBOXYLIC ACID STRUCTURE IN A SUBSTITUTE AT POSITION 14
US20090076071A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched retapamulin
US20090234125A1 (en) * 2007-11-26 2009-09-17 Eli Lancry Amorphous retapamulin and processes for preparation thereof
WO2009075776A1 (en) * 2007-12-05 2009-06-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of retapamulin and its intermediates
US8278313B2 (en) 2008-03-11 2012-10-02 Abbott Laboratories Macrocyclic spiro pyrimidine derivatives
US8436005B2 (en) 2008-04-03 2013-05-07 Abbott Laboratories Macrocyclic pyrimidine derivatives
US20100184987A1 (en) * 2008-11-13 2010-07-22 Teva Pharmaceutical Industries Ltd. Preparation of Retapamulin via its Pleuromutilin-thiol precursor
WO2010100720A1 (ja) * 2009-03-03 2010-09-10 独立行政法人放射線医学総合研究所 コリンエステラーゼ活性測定用試薬
SG177523A1 (en) 2009-07-14 2012-02-28 Albany Molecular Res Inc 5-ht3 receptor modulators, methods of making, and use thereof
CN102344397B (zh) * 2011-08-23 2013-09-04 浙江升华拜克生物股份有限公司 一种伐奈莫林盐酸盐的提纯方法
CN103626693B (zh) * 2012-08-28 2016-09-14 中国科学院上海药物研究所 一类截短侧耳素衍生物、其药物组合物及其合成方法与用途
CN103709093B (zh) * 2012-09-28 2016-06-08 山东亨利医药科技有限责任公司 含有并环的截短侧耳素类抗生素
CN111436896A (zh) 2014-07-21 2020-07-24 恩多巧爱思股份有限公司 多焦、多相机内窥镜***
EP3423159A4 (en) * 2016-03-02 2019-11-06 Anacor Pharmaceuticals, Inc. BORN SMALL MOLECULES
US10874679B2 (en) 2016-03-02 2020-12-29 Bill & Melinda Gates Foundation Boron-containing small molecules
EP3423065B1 (en) * 2016-03-02 2021-07-21 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
CN106496085B (zh) * 2016-09-21 2018-01-26 盐城市舜宝化工有限公司 合成盐酸沃尼妙林的中间体化合物以及盐酸沃尼妙林的制备方法
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN111574395B (zh) * 2020-06-18 2021-07-02 华南农业大学 一种具有酰胺侧链的截短侧耳素衍生物及制备与应用
AT523646B1 (de) 2020-07-21 2021-10-15 Gerd Dr Ascher Pharmazeutische Verbindungen, ihre Anwendung alleine oder in Kombination, zur Prophylaxe und lokalen Initial-Therapie bei bakteriellen und viralen Infektionen, insbesondere Coronaviren
US11155514B1 (en) * 2020-12-19 2021-10-26 Shaanxi University Of Science And Technology Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same
US11332430B1 (en) * 2021-01-25 2022-05-17 Xi'an Taikomed Pharmaceutical Technology Co., Ltd. Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same
CN112919463B (zh) * 2021-04-09 2021-10-26 南京理工大学 一种利用泰妙菌素废盐制备的活性炭及其制备方法
CN113121355B (zh) * 2021-04-13 2023-05-09 西安康诺化工有限公司 一种截短侧耳素大黄酸酯及其制备方法和应用
CN114736194A (zh) * 2022-03-29 2022-07-12 中牧实业股份有限公司 一种具有抗病原微生物活性的含吡啶季铵盐侧链的截短侧耳素衍生物及其制备方法与应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060542A (en) * 1969-07-25 1977-11-29 Biochemie Gesellschaft M.B.H. 14-Desoxy-14 thiocyanato-acetoxy-mutilin
US4208326A (en) 1971-10-05 1980-06-17 Sandoz Ltd. Pleuromutilin esters
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
US3919290A (en) 1972-10-03 1975-11-11 Sandoz Ltd Substituted 14-desoxy-mutilins
CH575375A5 (es) 1972-05-25 1976-05-14 Sandoz Ag
US4032530A (en) 1971-10-05 1977-06-28 Sandoz Ltd. Certain pleuromutilins
CH593912A5 (en) 1972-07-07 1977-12-30 Sandoz Ag Pleuromutilin derivs. - prepd. by acylating derivs. contg. a (4)-hydroxyalkyl-(1)-piperazinyl gp.
DE2404046C3 (de) 1974-01-29 1984-07-26 Henkel KGaA, 4000 Düsseldorf Verwendung von Carboxyl- bzw. Carboxylat- und Hydroxylgruppen aufweisenden Polymeren als Hautfeuchthaltemittel
US3987194A (en) 1975-05-12 1976-10-19 E. R. Squibb & Sons, Inc. Use of pleuromutilin derivatives for the treatment of swine dysentery
CH619450A5 (es) 1976-01-15 1980-09-30 Sandoz Ag
US4130709A (en) 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
GB2025930B (en) * 1978-06-01 1983-02-09 Sandoz Ltd Process for the production of pleuromutilin derivatives
DE2966635D1 (en) * 1979-01-12 1984-03-08 Sandoz Ag New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
ZA80175B (en) * 1979-01-12 1981-08-26 Sandoz Ltd New pleuromutilin derivatives, their production and use
FR2502951B1 (fr) 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AT400674B (de) 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
GB9201751D0 (en) 1992-01-28 1992-03-11 Smithkline Beecham Plc Compounds
AT397654B (de) 1992-05-04 1994-06-27 Biochemie Gmbh Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
CZ189197A3 (cs) 1994-12-23 1998-01-14 Dr. Karl Thomae Gmbh Piperazinové deriváty, způsob výroby a farmaceutický prostředek s jejich obsahem
CA2240467A1 (en) 1996-01-03 1997-07-17 Smithkline Beecham P.L.C. Carbamoyloxy derivatives of mutiline and their use as antibacterials
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
TR199900733T2 (xx) 1996-10-01 1999-07-21 Smithkline Beecham Corporation Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlar�n tedavisi i�in bir ilac�n imalat�nda mupirosin kullan�m�.
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US7875630B2 (en) 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph

Also Published As

Publication number Publication date
NO327392B1 (no) 2009-06-22
CA2307551A1 (en) 1999-05-06
AU742167B2 (en) 2001-12-20
EP1028961A1 (en) 2000-08-23
KR20010031654A (ko) 2001-04-16
DE122007000076I1 (de) 2008-02-14
DK1930330T3 (da) 2011-12-12
US6281226B1 (en) 2001-08-28
NL300304I1 (nl) 2008-01-02
JP2001521033A (ja) 2001-11-06
FR07C0057I2 (fr) 2008-05-16
DE69826704T2 (de) 2005-10-06
CY2007028I2 (el) 2009-11-04
PT1930330E (pt) 2011-10-31
SI1028961T1 (en) 2005-02-28
FR07C0057I1 (es) 2007-12-14
IL135811A (en) 2006-12-31
EP1028961B1 (en) 2004-09-29
DE69826704D1 (de) 2004-11-04
LU91372I9 (es) 2019-01-02
CO5021129A1 (es) 2001-03-27
SI1930330T1 (sl) 2011-12-30
CA2307551C (en) 2007-01-30
EP1930330A1 (en) 2008-06-11
CN1283197A (zh) 2001-02-07
DZ2634A1 (fr) 2003-03-08
MY130665A (en) 2007-07-31
WO1999021855A1 (en) 1999-05-06
USRE39128E1 (en) 2006-06-13
NO20002173D0 (no) 2000-04-27
EP1452534A1 (en) 2004-09-01
PT1028961E (pt) 2005-01-31
LU91372I2 (fr) 2007-12-24
NO2009023I2 (no) 2012-12-03
PL340254A1 (en) 2001-01-29
HUP0004040A1 (hu) 2001-05-28
CY2007028I1 (el) 2009-11-04
ZA989767B (en) 2000-04-28
AU742167C (en) 2003-08-07
EG24177A (en) 2008-09-28
PL197672B1 (pl) 2008-04-30
TR200001203T2 (tr) 2000-08-21
NL300304I2 (nl) 2008-03-03
CZ298543B6 (cs) 2007-10-31
ES2229538T7 (es) 2009-06-18
HU229792B1 (en) 2014-07-28
NO2009023I1 (no) 2009-10-12
CZ20001551A3 (cs) 2001-01-17
USRE43390E1 (en) 2012-05-15
HUS1400060I1 (hu) 2016-09-28
DK1028961T3 (da) 2005-01-03
JP4227729B2 (ja) 2009-02-18
HK1031376A1 (en) 2001-06-15
NO20091344L (no) 2000-06-05
CN1205211C (zh) 2005-06-08
BR9814747B1 (pt) 2010-12-14
EP1930330B1 (en) 2011-09-21
AU9636198A (en) 1999-05-17
KR100538721B1 (ko) 2005-12-26
DE122007000076I2 (de) 2010-03-25
JP2009040789A (ja) 2009-02-26
DK1028961T5 (da) 2009-03-09
PE123299A1 (es) 2000-02-05
NO20002173L (no) 2000-06-05
PL191927B1 (pl) 2006-07-31
DE69826704T3 (de) 2009-07-23
IL135811A0 (en) 2001-05-20
UY25225A1 (es) 2000-12-29
ATE277925T1 (de) 2004-10-15
ES2371205T3 (es) 2011-12-28
CY1112062T1 (el) 2015-11-04
TWI232861B (en) 2005-05-21
ATE525373T1 (de) 2011-10-15
BR9814747A (pt) 2001-11-20
EP1028961B3 (en) 2008-12-03
NZ504203A (en) 2002-11-26
ES2229538T3 (es) 2005-04-16
HUP0004040A3 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
AR015987A1 (es) DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO.
ES2193142T3 (es) Uso de benzotiofenos para el tratamiento de hipercolesterolemia.
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR017796A1 (es) DERIVADOS DE 2-ARIL-8-OXODIHIDROPURINA, PROCEDIMIENTOS PARA PREPARARLOS, COMPUESTOS INTERMEDIARIOS DE APLICACIoN EN DICHOS PROCEDIMIENTOS, COMPOSICIONES FARMACEUTICAS, Y SU USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ESTADOS DE ANSIEDAD.
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
ES2159591T3 (es) Composicion de liberacion controlada.
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2158778B1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
AR019053A1 (es) Uso de 2&#39;2&#39;-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
MX9401080A (es) Compuestos heteroaromaticos.
YU47338B (sh) Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
DE69322411D1 (de) Arzneizusammensetzungen enthaltend tandospiron oder seine analoge
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE3770048D1 (de) Synergistin-derivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE9103776D0 (sv) New compounds
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0443957T3 (da) Hidtil ukendte steroid-forbindelser med en spirogruppe i position 17, en fremgangsmåde og mellemprodukter til fremstilling deraf, deres anvendelse som lægemiddel og farmaceutiske præparater med indhold deraf
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase

Legal Events

Date Code Title Description
FG Grant, registration